Longeveron Inc. (LGVN) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Longeveron Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.416 Greetings and welcome to Longevity 2025 Full Year Financial Results 00:00:05.416 -- 00:00:10.721 and Business Update. At this time, all participants are on a listen-only mode. 00:00:10.721 -- 00:00:14.644 A question and answer session will follow the formal presentation. 00:00:14.644 -- 00:00:19.428 If anyone should require operator assistance during the conference, please press star 00:00:19.428 -- 00:00:25.494 zero on your telephone keypad. As a reminder, this conference call is being recorded. 00:00:25.494 -- 00:00:29.697 I would now like to introduce your host, Jenny Coben. 00:00:29.697 -- 00:00:32.478 Thank you, you may begin. 00:00:33.803 -- 00:00:38.970 Good afternoon, everyone, and thank you for joining us today to review Longevron's 2025 00:00:38.970 -- 00:00:43.336 full-year financial results and business updates. 00:00:43.336 -- 00:00:48.524 After the U.S. markets closed today, we issued a press release with the financial results 00:00:48.524 -- 00:00:53.971 for 2025, which can be found under the Investors section of the Longevron 00:00:53.971 -- 00:00:55.514 website. 00:00:55.514 -- 00:01:00.921 On the call today are Stephen Willard, Chief Executive Officer, Joshua Hare, 00:01:00.921 -- 00:01:06.069 Co-Founder, Chief Science Officer and Executive Chairman of the Board, 00:01:06.069 -- 00:01:11.198 Natalia Agafanova, Chief Medical Officer, and Lisa Locklear, Chief 00:01:11.198 -- 00:01:13.381 Financial Officer. 00:01:13.381 -- 00:01:18.169 As a reminder, during this call, we will be making forward-looking statements. 00:01:18.169 -- 00:01:23.037 These statements are subject to certain risks and uncertainties that could cause actual 00:01:23.037 -- 00:01:26.532 results to differ materially from these statements. 00:01:26....